MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway-Reference-Cited by-同舟云学术

MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway

Published:2023-12 Issue: Volume:34 Page:102054
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Obata Taisuke,Tsutsumi Koichiro,Ueta Eijiro,Oda Takashi,Kikuchi Tatsuya,Ako Soichiro,Fujii Yuki,Yamazaki Tatsuhiro,Uchida Daisuke,Matsumoto Kazuyuki,Horiguchi Shigeru,Kato Hironari,Okada Hiroyuki,Otsuka Motoyuki^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference72 articles.

1. Biliary tract cancer;Valle;Lancet,2021

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA. Cancer J. Clin.,2021

3. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat. Rev. Gastroenterol. Hepatol.,2020

4. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Valle;Ann. Oncol.,2016

5. How I treat biliary tract cancer;Lamarca;ESMO open,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression;Frontiers in Immunology;2024-09-03

2. Exosomal miR-141-3p Induces Gemcitabine Resistance in Biliary Tract Cancer Cells;Anticancer Research;2024-06-26

3. Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide in pancreatic cancer;International Journal of Pharmaceutics;2024-04

4. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives;Expert Review of Clinical Pharmacology;2024-03-15